Literature DB >> 2068183

Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma.

E S Srivatsan1, V Murali, R C Seeger.   

Abstract

Partial monosomy for the short arm of chromosome 1 is a frequent cytogenetic abnormality in neuroblastomas. Molecular genetic analysis of tumor samples using chromosome specific polymorphic DNA markers has identified somatic loss of heterozygosity for alleles on chromosomes 1p (1p36.1-1p36.3) and 14q. In order to determine if other chromosomal losses occur and to further investigate chromosome 14, we used polymorphic DNA markers localized to chromosome 11 and 14 to analyze fifteen neuroblastomas and corresponding constitutional cells. Somatic loss of heterozygosity was observed in 5 of 12 informative cases (42%) for chromosome 11q (11q13-11q23) and 4 of 12 cases (33%) for chromosome 14q specific alleles. Two of the five tumors that had lost 11q alleles retained heterozygous alleles for sequences on 14q. The other three samples had lost both the 11q and 14q allelic sequences. These results suggest that in addition to chromosomes 1p and 14q, sequences localized to 11q may also play an important role in the development and/or progression of neuroblastomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2068183

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  9 in total

Review 1.  Neuroblastoma as a neurobiological disease.

Authors:  N F Schor
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

Review 2.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

3.  Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus.

Authors:  H Caron; P van Sluis; R Buschman; R Pereira do Tanque; P Maes; L Beks; J de Kraker; P A Voûte; G Vergnaud; A Westerveld; R Slater; R Versteeg
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

4.  Bioinformatics analysis of recurrent deletion regions in neuroblastoma.

Authors:  Hasan Onur Caglar
Journal:  Med Oncol       Date:  2022-01-20       Impact factor: 3.064

5.  Allelic imbalance on chromosome 5q predicts long-term survival in neuroblastoma.

Authors:  S J Meltzer; S P O'Doherty; C N Frantz; K Smolinski; J Yin; A B Cantor; J Liu; M Valentine; G M Brodeur; P E Berg
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

6.  Sparstolonin B, a novel plant derived compound, arrests cell cycle and induces apoptosis in N-myc amplified and N-myc nonamplified neuroblastoma cells.

Authors:  Ambrish Kumar; Daping Fan; Donald J Dipette; Ugra S Singh
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

7.  Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene.

Authors:  K Ejeskär; H Aburatani; J Abrahamsson; P Kogner; T Martinsson
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

8.  Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Authors:  W D Foulkes; I G Campbell; G W Stamp; J Trowsdale
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

9.  No evidence for involvement of SDHD in neuroblastoma pathogenesis.

Authors:  Katleen De Preter; Jo Vandesompele; Jasmien Hoebeeck; Caroline Vandenbroecke; Jöel Smet; Annick Nuyts; Geneviève Laureys; Valérie Combaret; Nadine Van Roy; Frank Roels; Rudy Van Coster; Marleen Praet; Anne De Paepe; Frank Speleman
Journal:  BMC Cancer       Date:  2004-08-24       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.